< Back to companies
Protyon

Protyon

Groningen, Netherlands

Protyon is a digital health venture specializing in oncology that supports clinical decision-making through advanced molecular modeling. By generating 3D digital models based on patient-specific cancer mutation genetic codes, the company predicts the effectiveness of targeted therapies. This enables clinicians to choose the best available treatment options, aiming to increase patient longevity and reduce healthcare costs by eliminating ineffective treatments. Additionally, Protyon offers educational courses for clinicians and computational prediction services for life science research partners to enhance precision medicine.

Only accessible to MedStartr community members. Join now

Company Info

Website
protyon.tech
Only accessible to MedStartr community members. Join now

What do you think of Protyon?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Only accessible to MedStartr community members. Join now